- Home
- HAYW vs ACAD Comparison
HAYW vs ACAD Comparison
Compare HAYW & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAYW
- ACAD
- Stock Information
- Founded
- HAYW 1925
- ACAD 1993
- Country
- HAYW United States
- ACAD United States
- Employees
- HAYW N/A
- ACAD N/A
- Industry
- HAYW Electronic Components
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- HAYW Technology
- ACAD Health Care
- Exchange
- HAYW Nasdaq
- ACAD Nasdaq
- Market Cap
- HAYW 3.2B
- ACAD 2.6B
- IPO Year
- HAYW 2021
- ACAD 2004
- Fundamental
- Price
- HAYW $16.06
- ACAD $16.77
- Analyst Decision
- HAYW Hold
- ACAD Buy
- Analyst Count
- HAYW 5
- ACAD 19
- Target Price
- HAYW $16.80
- ACAD $26.44
- AVG Volume (30 Days)
- HAYW 2.4M
- ACAD 1.4M
- Earning Date
- HAYW 10-29-2024
- ACAD 11-06-2024
- Dividend Yield
- HAYW N/A
- ACAD N/A
- EPS Growth
- HAYW 40.94
- ACAD N/A
- EPS
- HAYW 0.43
- ACAD 0.78
- Revenue
- HAYW $1,003,000,000.00
- ACAD $929,236,000.00
- Revenue This Year
- HAYW $5.29
- ACAD $35.78
- Revenue Next Year
- HAYW $7.08
- ACAD $8.58
- P/E Ratio
- HAYW $37.36
- ACAD $21.60
- Revenue Growth
- HAYW 3.09
- ACAD 47.06
- 52 Week Low
- HAYW $11.54
- ACAD $14.15
- 52 Week High
- HAYW $16.87
- ACAD $32.59
- Technical
- Relative Strength Index (RSI)
- HAYW 58.24
- ACAD 58.08
- Support Level
- HAYW $15.88
- ACAD $14.41
- Resistance Level
- HAYW $16.22
- ACAD $18.71
- Average True Range (ATR)
- HAYW 0.52
- ACAD 0.67
- MACD
- HAYW -0.05
- ACAD 0.22
- Stochastic Oscillator
- HAYW 39.10
- ACAD 54.88
About HAYW Hayward Holdings Inc.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.0 billion in revenue in 2023.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.